Hepatocellular Carcinoma
Conditions
Interventions
Surgical group:NK cells therapy
Minimally invasive treatment group:NK cells therapy
Advanced liver cancer treatment group:NK cells therapy
Sponsors
302th Hospital infectious disease treatment and research center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. The expected survival of more than 6 months; 2. Patients with surgical resection of HCC patients; 3. Patients with minimally invasive treatment, such as Radiotherapy, chemotherapy, radiofrequency ablation and TACE; 4. Advanced liver cancer patients who can not carry out surgery, radiotherapy and minimally invasive treatment.
Exclusion criteria
Exclusion criteria: 1. Patients with alcohol or intravenous drug addicts in the last year; 2. With any autoimmune disease in patients; 3. At the same time, there are other viral infections, such as HIV; 4. Combined with abdominal infection, hepatic encephalopathy, gastrointestinal bleeding and so on; 5. Allergies, had a history of blood products allergies; 6. Pregnant women, lactating women or estrogen contraceptives; 7. Patients who have been or are using glucocorticoid therapy within six months; 8. Patients who have received other biotherapies within six months; 9. Who are unable or unwilling to provide informed consent or who can not comply with the research request.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Survival;Clinical detection;Immunological detection; | — |
Countries
China
Contacts
Public ContactFusheng Wang
Treatment and Research Center for Infectious Diseases, 302 Hospital
Outcome results
None listed